The largest database of trusted experimental protocols

Dc cholesterol

Manufactured by Avanti Polar Lipids
Sourced in United States

DC-cholesterol is a laboratory reagent used in the synthesis and analysis of lipid-based compounds. It is a cholesterol derivative that serves as a precursor or intermediate in various chemical reactions and assays involving lipids and lipid-like molecules.

Automatically generated - may contain errors

5 protocols using dc cholesterol

1

Synthesis of Cationic Lipid Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
A certain mass of lipid [5 mg DPPC, 2 mg DSPE-PEG (2000)-Amine and 2 mg DC-cholesterol(Avanti Polar Lipids, Inc, Alabaster, AL, USA)] were mixed together and dissolved into 10 mL trichloromethane(CHCl3) (Fisher Scientific, Waltham, MA, USA). The solution was moved to the rotary evaporator (Yarong Inc, Shanghai, China) at 50 °C to remove the organic solvent and form a thin lipid film. One hour later, the resulting thin lipid films was hydrated in 2 mL Double steaming water forming a translucent opalescent suspension. Then 100 µl of Perfluorohexane (PFH) was dropwise into suspension after which the suspension was emulsified in an ice bath using a sonicator (Sonics &Materials Inc., Newtown, CT, USA) with power of 130 W for 5 min (5 s on and 5 s off), then the prepared cationic liquid nanoparticles (CL-NPs) were harvested. The nanoemulsions were centrifuged at 6000 rpm for 5 min and then washed in Double steaming water to wipe off disasociated lipids and PFH. The centrifugation and washing process were repeated three times. Finally, the prepared CL-NPs were stored at 4 °C for later use. To prepare fluorescent nanodroplets, DiI (1 mg) or DiR (1 mg) fluorescent dye were added to the lipid solution and aluminum foil papers was used to prevent light exposure.
+ Open protocol
+ Expand
2

PRINT-Based PLGA Nanoparticle Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
PRINT technology was used to manufacture 80×320 nm poly (lactic co-glycolic acid) (PLGA, 50:50, 35 kDa, Lakeshore Biomaterials) particles as previously described [34 (link),35 (link)]. In short, PLGA and DC-cholesterol (Avanti Polar Lipids) were dissolved in chloroform (9:1 w/w ratio) and casted into a thin film on a PET-sheet (KRS Plastics). The film was oriented in order to contact the molds and carefully heated. Next, the film was split and the mold content was transferred to a second PET-sheet by passing through a laminator. Then water with 0.1% polyvinyl alcohol (PVOH) was added to the PET-sheet to release the nanoparticles (NPs). The harvested particles were sterilized and concentrated by sterile filtration and tangential flow filtration.
To adsorb the rE proteins to NP surfaces, rE was incubated with PLGA NPs in a 1% rE/NP (w/w%) ratio for 15 mins at room temperature in 0.1% PVOH in water with 9.25% sucrose to establish 100% adsorption efficiency for all serotypes.
+ Open protocol
+ Expand
3

Synergistic Nanotherapy for Cancer Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Distearoylphosphatidylglycerol (DPPG), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), and DC-cholesterol (DC-CHOL) were all provided by Avanti Polar Lipids (700 Industrial Park Drive, Alabaster, Alabama, USA). Additionally, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)]-2000&C-RGD (DSPE-2000&C-RGD) were purchased from Xi’an Ruixi Biological Technology Co., Ltd. Banoxantrone (AQ4N) and perfluorohexane (PFH) were supplied by Abcam and Sigma-Aldrich, respectively. Haematoporphyrin monomethyl ether (HMME) was purchased from Macklin Bio Co., Ltd. The 4T1 mouse mammary carcinoma cell line and the human umbilical vein endothelial cell line (HUVECs) were supplied by Nanjing Ke Bai Biotechnology Co., Ltd. Cell Counting Kit-8 (CCK-8) was purchased from Dojindo. Singlet oxygen sensor green (SOSG) was purchased from Invitrogen. Furthermore, 4,6-diamidino-2-phenylindole (DAPI) was purchased from Wuhan Boster Biotech Company, and 2′,7′-dichlorofluorescein diacetate (DCFH-DA) was purchased from Shanghai Beyotime Biotechnology Co., Ltd.
+ Open protocol
+ Expand
4

Liposome Preparation via Dry-Film Method

Check if the same lab product or an alternative is used in the 5 most similar protocols
The liposomes were generated with the dry-film method.55 (link), 56 (link) Therefore, the cationic lipid DC-cholesterol (3β-[N-(N’,N’-dimethylaminoethane)-carbamoyl]cholesterol hydrochloride; Avanti Polar Lipids) and the neutral lipid DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; Avanti Lipids), both dissolved in chloroform, were mixed together in the ratio of 1:2 in a glass flask. Drying of the lipids took place under argon gas flow excluding O2. To remove chloroform completely, we put the glass flask with the formed lipid cake into an evaporator overnight. After the evaporation, the lipid cake was rehydrated with nuclease-free H2O (QIAGEN). After several minutes of vortexing, the glass flask with the formed multilamellar liposomes was placed in a sonication bath for 30 min to form unilamellar liposomes. Finally, the lipids were extruded with the mini extruder using a membrane with 200 nm pores (Avanti Polar Lipids).
+ Open protocol
+ Expand
5

Cationic Nanoliposome Formulation for mRNA Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) and DC-Cholesterol were purchased from Avanti Polar Lipids (U. S. A.) and used without further purification. The lyophilized lipids were dissolved in chloroform (Sigma-Aldrich, Germany) at 25 mg/ml. Each lipid was further diluted to a convenient working solution of 3 mg/ml. The formulation of 2:1 of DC-Cholesterol and DOPE was used, vortexed, and the solvent evaporated using N2 gas for several minutes. Residual solvent was removed by vacuum for at least 24 h via the dry film method.13 (link),17 (link)
The obtained lipid film was hydrated with 1 ml nuclease-free H2O by vortexing. After 10 min at room temperature, a cloudy suspension of multilamellar liposomes was sonicated until the solution cleared. The resulting liposomes were reduced in size and sterilized by extrusion about 21 times using an extruder (Avanti, U. S. A.) and a PC membrane 0.1 µm (Avanti, U. S. A.). The resulting cationic nanoliposomes (NLps) were stored in glass vials at 4 ºC before usage. Nanoplexes were formed via incubation of mRNA with NLps at room temperature for 20 min, in either Opti-MemTM (Gibco, Massachusetts, U. S. A.) or the desired cell media without fetal bovine serum (FBS).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!